Literature DB >> 35338309

A trojan horse to target spliceosome mutant cells.

Ulrike Harjes1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35338309     DOI: 10.1038/s41568-022-00472-3

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   69.800


× No keyword cloud information.
  1 in total

1.  Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells.

Authors:  Khrystyna North; Salima Benbarche; Bo Liu; Joseph Pangallo; Sisi Chen; Maximilian Stahl; Jan Philipp Bewersdorf; Robert F Stanley; Caroline Erickson; Hana Cho; Jose Mario Bello Pineda; James D Thomas; Jacob T Polaski; Andrea E Belleville; Austin M Gabel; Dylan B Udy; Olivier Humbert; Hans-Peter Kiem; Omar Abdel-Wahab; Robert K Bradley
Journal:  Nat Biotechnol       Date:  2022-03-03       Impact factor: 68.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.